 | Xcellerate® Clinical Trial Optimization®
When a large multinational client asked Covance to conduct a Phase III trial on a promising new colorectal cancer drug, their rigorous patient selection criteria initially caused some concern. How long would it take to identify, recruit and retain sufficient qualifying patients? To learn how Covance delivered the study ahead of schedule, click here. | |
| Health Care & Policy |  |  | | - FDA approves midstage study of BioLineRx's leukemia drug
BioLineRx obtained FDA approval to initiate a Phase IIa study of BL-8040, its experimental drug for acute myeloid leukemia. The main goal of the study is to evaluate the safety and tolerability of the drug in up to 50 AML patients. The trial will be carried out in the U.S. and Israel. RTT News (4/10)       - Obama's budget proposal delivers good and bad news for biotech firms
 U.S. President Barack Obama's $3.77 trillion budget proposal for fiscal 2014 delivers mixed news for the biopharmaceutical industry, Mari Serebrov writes. The proposal's tax reforms may benefit small biotechs, but it would prevent major drugmakers from moving profits out of the country to avoid U.S. taxes. While the proposal would raise the FDA'S budget to $4.7 billion, the agency would still see a $15 million decline in funding for its drug, medical device and biologics programs. Obama's proposal to cut Medicare spending may also harm the drug industry. BioWorld (free content) (4/10) | Company & Financial News | | | | - Inovio lands $3.5M grant to further develop mass vaccine device
The National Institute of Allergy and Infectious Diseases awarded Inovio Pharmaceuticals a $3.5 million grant to further develop a next-generation DNA vaccine delivery device that can simultaneously administer multiple synthetic vaccines through skin surface electroporation. The device is being co-developed with Chief Scientist Connie Schmaljohn of the Army Medical Research Institute of Infectious Diseases. The goal is to create a device that will allow fast vaccination of U.S. troops and the protection of the public from pandemic threats. Genetic Engineering & Biotechnology News (4/10) | Industry Deals | | | | | Food & Agriculture | | | | - Dow's biotech research facility inaugurated in Ind.
Dow AgroSciences has officially opened its new biotechnology research center in Indiana. The 19-acre site, which will employ more than 200 researchers, will develop products that could boost agricultural production. "Biotechnology is going to allow us to produce more food with less land, less water, and in a more sustainable way," said Dow AgroSciences CEO and President Antonio Galindez. Hoosier Ag Today (Clermont, Ind.) (4/10) | Industrial & Environmental | | | | - EIA: E85 use grew 52% from 2010 to 2011
Alternative-fuel use in the transportation sector rose 13% from 2010 to 2011, to 515.62 million gasoline-equivalent gallons, according to the Energy Information Administration. Because of the approaching blend wall, E10 use remained steady while E85 use increased 52%. EthanolProducer.com (4/10)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Evidence, Coverage and Incentives: A PMC/BIO Solutions Summit
BIO and the Personalized Medicine Coalition have partnered to bring together all stakeholders to discuss potential solutions to advance personalized medicine on Wednesday in Washington, D.C. A key focus of the summit is a determination of the nature and level of evidence necessary to make reliable and appropriate decisions on the coverage, regulation and adoption of personalized medicine products. Other topics to be addressed are market access issues for companion diagnostics and incentives for the development of personalized medicine products. Learn more and register.
| SmartQuote | | | |  | To live is so startling it leaves little time for anything else."
--Emily Dickinson,
American poet  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, April 10, 2013
- Tuesday, April 09, 2013
- Monday, April 08, 2013
- Friday, April 05, 2013
- Thursday, April 04, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment